We next analyzed a cohort of 148 invasive breast cancer samples (Supplementary Table 1) and compared Id2 expression between IDC of no specific subtype (IDC-NST) and ILC using immunohistochemistry (IHC). This evidence concerns the gene ID2 and invasive breast carcinoma.